DoW Rare Cancers Idea Development Award
Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the potential to yield high-impact findings and new avenues of investigation. Offered by Defense Health Agency Contracting Activity - DHACA; awards $7.3M; applications due November 18, 2026.
Key Facts
- Funder
- Defense Health Agency Contracting Activity - DHACA
- Award amount
- $7.3M
- Deadline
- November 18, 2026
- Geography
- United States
- Categories
- Research
- Status
- Open
About This Grant
Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the potential to yield high-impact findings and new avenues of investigation. Distinctive Features: The RCRP encourages applicants to include an exploratory aim or sub-aim to support any necessary discovery-driven research. Preliminary data with disease-specific rationale are required. However, these data do not necessarily need to...
Full requirements and application instructions: official listing.
Similar Open Grants
Department of Defense HIV/AIDS Prevention Program
Defense Health Agency Contracting Activity - DHACA
DOD Defense Health Agency (DHA) Research & Development FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research
Defense Health Agency Contracting Activity - DHACA
DoW Spinal Cord Injury, Translational Research Award
Defense Health Agency Contracting Activity - DHACA
DoW Vision, Translational Research Award
Defense Health Agency Contracting Activity - DHACA
DoW Spinal Cord Injury, Clinical Translation Research Award
Defense Health Agency Contracting Activity - DHACA
DoW Vision, Investigator-Initiated Research Award
Defense Health Agency Contracting Activity - DHACA
DoW Rare Cancers Resource and Community Development Award
Defense Health Agency Contracting Activity - DHACA
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
National Institutes of Health
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
National Institutes of Health
National Science Foundation Fostering Interdisciplinary Networks to Develop Emergent and Responsive Solutions Foundry (NSF FINDERS FOUNDRY)
U.S. National Science Foundation